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Introduction
Malaria continues to pose an enormous health problem worldwide, with approximately 200 million new 
cases annually (1). In endemic areas, blood-stage Plasmodium falciparum infection of  children results in a 
spectrum of  clinical findings, from asymptomatic parasitemia to uncomplicated malaria to life-threatening 
severe malaria and death (2). Compared with adults and adolescents, young children living in endemic 
areas where transmission is stable and relatively intense are susceptible to more frequent symptomatic 
infections and severe disease, and, despite decreasing transmission in some areas, the burden of  malaria in 
young children in sub-Saharan Africa remains substantial (3, 4). The mechanisms by which this age-related 
naturally acquired immunity to clinical malaria is generated and maintained are poorly understood (5).
BACKGROUND. Inflammation and monocytes are thought to be important to human malaria 
pathogenesis. However, the relationship of inflammation and various monocyte functions to acute 
malaria, recovery from acute malaria, and asymptomatic parasitemia in endemic populations is 
poorly understood.
METHODS. We evaluated plasma cytokine levels, monocyte subsets, monocyte functional 
responses, and monocyte inflammatory transcriptional profiles of 1- to 10-year-old Kenyan children 
at the time of presentation with acute uncomplicated malaria and at recovery 6 weeks later; these 
results were compared with analogous data from asymptomatic children and adults in the same 
community.
RESULTS. Acute malaria was marked by elevated levels of proinflammatory and regulatory 
cytokines and expansion of the inflammatory “intermediate” monocyte subset that returned to 
levels of healthy asymptomatic children 6 weeks later. Monocytes displayed activated phenotypes 
during acute malaria, with changes in surface expression of markers important to innate and 
adaptive immunity. Functionally, acute malaria monocytes and monocytes from asymptomatic 
infected children had impaired phagocytosis of P. falciparum–infected erythrocytes relative to 
asymptomatic children with no blood-stage infection. Monocytes from both acute malaria and 
recovery time points displayed strong and equivalent cytokine responsiveness to innate immune 
agonists that were independent of infection status. Monocyte transcriptional profiles revealed 
regulated and balanced proinflammatory and antiinflammatory and altered phagocytosis gene 
expression patterns distinct from malaria-naive monocytes.
CONCLUSION. These observations provide insights into monocyte functions and the innate immune 
response during uncomplicated malaria and suggest that asymptomatic parasitemia in children is 
not clinically benign.
FUNDING. Support for this work was provided by NIH/National Institute of Allergy and Infectious 
Diseases (R01AI095192-05), the Burroughs Wellcome Fund/American Society of Tropical Medicine 
and Hygiene, and the Rainbow Babies & Children’s Foundation.
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Cells of  the monocyte/macrophage lineage play a key role at the interface between innate and adap-
tive immunity and are thought to be essential for host protection against malaria (6). Monocytes perform 
crucial effector functions in host defense against P. falciparum infection, including nonopsonic and opsonic 
phagocytosis of  P. falciparum–infected erythrocytes (IEs) (7–11). Monocyte interactions with products of  
the parasite itself, e.g., hemozoin and glycophosphatidylinositols (12), and erythrocyte byproducts result-
ing from hemolysis, e.g., extracellular heme (13), by innate immune receptors, such as TLRs, have been 
observed to affect downstream inflammatory cytokine production (14–16) and modulate adaptive immune 
responses (17, 18). While activation of  the innate immune response is necessary to control blood-stage 
infection, excessive activation of  monocytes and other innate immune cells promotes disease pathogenesis. 
Similar to sepsis, monocyte release of  proinflammatory cytokines, such as IL-1β and TNF, during acute 
malaria augments systemic inflammation and is associated with signs of  severe malaria pathogenesis, e.g., 
lactic acidosis, hypoglycemia, respiratory distress (19). In severe malaria anemia, monocytes not only con-
trol infection by phagocytosing infected and uninfected erythrocytes, but also produce inflammatory medi-
ators, such as IL-6, NO, and TNF, that impair erythropoiesis (20). Better characterization of  the changes in 
monocyte subpopulations and their functions during symptomatic and asymptomatic infection would aid 
in determining the factors that underlie the balance between immune protection and immunopathology.
Circulating human monocytes are a heterogeneous population that has been classified into three subsets 
based on levels of  expression of  CD14 (LPS coreceptor) and CD16 (the low-affinity Fcγ receptor III [Fcγ-
RIII]). The subsets include CD14++CD16– “classical,” CD14++CD16+ “intermediate,” and CD14+CD16++ 
“nonclassical” monocytes (21). These subsets vary in differentiation properties, migratory capabilities, and 
cytokine production. The two CD16+ subsets appear to have more activated, proinflammatory phenotypes 
(22–24). Increased proportions of  circulating CD16+ intermediate and nonclassical monocytes have been 
associated with acute falciparum malaria (25–27). Evidence suggests that the CD16+ subpopulations have 
enhanced antiparasitic activity (26, 28, 29), though there are still significant gaps in our understanding of  
the functional roles of  monocyte subpopulations during malaria. In this study, we characterized systemic 
inflammation and the monocyte subset phenotypes, monocyte functions relevant to malaria pathogenesis, 
and monocyte gene expression profiles of  Kenyan children at the time of  presentation with acute uncom-
plicated malaria and 6 weeks later, when they were asymptomatic following administration of  antimalarial 
drugs. These data were compared with results of  studies performed using plasma and monocytes from 
healthy asymptomatic infected and uninfected Kenyan children and adults living in the same community.
Results
Clinical presentations and laboratory features of  the study population. The study was conducted in an area of  
western Kenya where transmission of  P. falciparum and child malaria morbidity are increasing, despite 
the widespread distribution of  long-lasting insecticidal nets (30, 31). Demographic features and pertinent 
clinical laboratory results for children with acute uncomplicated malaria, their samples obtained 6 weeks 
after treatment (6-week recovery samples), and healthy asymptomatic children and adults from the same 
communities where malaria cases were recruited are presented in Supplemental Table 1 (supplemental 
material available online with this article; https://doi.org/10.1172/jci.insight.95352DS1). The median 
ages of  children with acute malaria and healthy community children were similar (4.8 and 5.7 years). The 
median density of  peripheral blood asexual parasitemia of  children with acute malaria was 48,870/μl. 
Blood smears were P. falciparum negative for all uncomplicated malaria cases 2 weeks after a 3-day course 
of  artemether-lumefantrine; at 6 weeks, all of  these children were asymptomatic (no fever or malaria symp-
toms), but 41% were reinfected as detected by conventional PCR or blood smear. There was no difference 
in age between children with acute malaria who had asymptomatic parasitemia at their 6-week recovery 
visit compared with children who remained uninfected (PCR negative) at 6 weeks (median 4.8 years in 
both groups). The proportions of  healthy community control children and adults with asymptomatic par-
asitemia (blood smear or PCR positive) were 52.5% and 42.8%, respectively. The median plasma level of  
P. falciparum histidine-rich protein 2 (PfHRP2) at the time of  presentation with acute malaria was 131.3 ng/
ml, consistent with the parasite biomass associated with uncomplicated disease (32). Plasma PfHRP2 levels 
correlated directly with the density of  asexual parasitemia (Supplemental Figure 1). Absolute leukocyte 
and monocyte counts among the four groups were similar. Granulocyte counts were increased and lym-
phocyte counts were decreased during acute malaria compared with recovery values and those of  healthy 
children (P < 0.0001). The platelet count of  children with acute malaria was lower than that of  the other 
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groups but within the normal range for this parameter. Hemoglobin levels were lower (P < 0.05) at the time 
of  presentation with acute malaria relative to recovery values at 6 weeks and those of  healthy children in 
the same community.
Cytokines and acute-phase reactants in acute malaria and asymptomatic parasitemia. Plasma levels of  16 cyto-
kines and acute-phase reactants were compared for acute malaria cases, their matching 6-week recovery 
samples, and healthy child community controls. Compared with 6-week recovery samples and samples from 
healthy children in the community, acute malaria was associated with a 1.5- to 9.4-fold increase in circu-
lating levels of  the proinflammatory cytokines IFN-γ–induced protein 10 (IP-10, also known as CXCL10), 
IFN-γ, TNF, and IL-6 (Figure 1). IL-10, which is produced by cells of  both the innate and adaptive immune 
systems and has diverse antiinflammatory as well as antimicrobial functions, was elevated 51.2-fold during 
acute malaria (P < 0.0001). Plasma levels of  soluble TNF receptors 1 and 2 (sTNF-R1 and sTNF-R2), solu-
ble CD14, soluble B cell–activating factor (BAFF), and C-reactive protein (CRP) were also elevated during 
acute malaria (P < 0.0001), indicative of  a systemic inflammatory state. Data for all 16 plasma cytokines 
and acute-phase reactants are presented in Supplemental Table 2. Plasma IL-10, IL-6, and TNF correlated 
directly with PfHRP2 levels (r = 0.5, 0.6, and 0.7, respectively, P < 0.001) during acute malaria. In contrast, 
plasma IFN-γ and IL-12p70 correlated inversely with PfHRP2 levels (r = –0.3, P < 0.05) (Supplemental Fig-
ure 1). There was no relationship between PfHRP2 and the remaining plasma cytokines.
We also compared plasma cytokine profiles of  healthy community control children with asymptomatic 
infection determined by positive blood smear, with asymptomatic infection determined by positive P. falciparum 
PCR (blood smear negative), and without P. falciparum infection (P. falciparum PCR negative). Of note, healthy 
Figure 1. Acute uncomplicated malaria is associated with a robust proinflammatory cytokine response and systemic inflammation. Plasma 
cytokine and acute-phase reactant levels were compared in samples from cases of acute uncomplicated malaria and 6-week recovery samples (n = 60 
pairs) and samples from heathy child controls (n = 40). Bars represent medians with interquartile ranges. Wilcoxon matched-pairs rank test was used 
to compare acute malaria samples to 6-week recovery samples. Kruskal-Wallis test was used to compare healthy child samples to acute malaria and 
6-week recovery samples. ****P < 0.0001. IP-10, IFN-γ–induced protein 10.
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child controls had no episodes of febrile malaria or receipt of antimalarials in the 2 months preceding study 
enrollment. Low-grade inflammation was associated with asymptomatic blood-stage infection detectable by 
peripheral blood smear, with elevated levels of TNF, IL-10, and CRP when compared with children with pos-
itive P. falciparum PCR but negative blood smear and uninfected children (P < 0.05). There was a trend toward 
increased plasma levels of IP-10, sTNF-R1, and sTNF-R2 in children with asymptomatic infection compared 
with uninfected children, though these differences were not statistically significant (Supplemental Table 3).
Monocyte subsets and surface markers of  innate and adaptive immunity. Monocyte subset proportions were 
determined by flow cytometry. The gating strategy is shown in Figure 2A. There was no difference in 
the proportions of  the classical CD14++CD16– monocyte subset for samples from acute malaria cases, 
6-week recovery samples, and samples from healthy Kenyan child and adult controls (Figure 2B). In con-
trast, acute malaria was associated with an expansion of  intermediate CD14++CD16+ monocytes com-
pared with 6-week recovery samples and samples from healthy child controls (median values 19.5% vs. 
10.6% and 8.8%, respectively; P < 0.05; Figure 2C). Healthy adults had higher proportions of  nonclassical 
CD14+CD16++ monocytes compared with children with acute malaria (median values 10.2% vs. 4.8%; P 
= 0.02), but there was no difference among samples from children with acute malaria, 6-week recovery 
samples, and samples from healthy community children (Figure 2D).
Cell surface expression of markers important to innate and adaptive immunity were altered on the three 
monocyte subsets during acute malaria compared with 6-week recovery samples and samples from healthy 
child controls. TLR2 and TLR4 expression (Figure 3A) was increased on intermediate monocytes during acute 
malaria compared with recovery samples and samples from healthy children, with no differences in expression 
on the classical or nonclassical subsets. In contrast, surface expression of the scavenger receptor CD36, which is 
important to nonopsonic phagocytosis of IEs, was decreased on both classical and nonclassical subsets during 
Figure 2. Acute uncomplicated malaria is associated with an expansion of the intermediate monocyte subset. (A) Gating strategy to calculate propor-
tions of circulating monocyte subsets. Doublets were excluded, and monocytes were gated based on forward- and side-scatter properties. Dead cells 
were excluded based on Fixable Violet staining. The 3 subsets were determined based on CD14 and CD16 expression (classical CD14++CD16–, intermedi-
ate CD14++CD16+, and nonclassical CD14+CD16++). Proportions of all circulating monocytes that are (B) classical, (C) intermediate, and (D) nonclassical for 
samples from cases of acute malaria, 6-week recovery (n = 35 pairs), healthy child controls (n = 17), and healthy adult controls (n = 14). Bars represent the 
median values with interquartile ranges. Wilcoxon matched-pairs rank test was used to compare acute malaria to 6-week recovery samples. Kruskal-Wallis 
test was used to compare unmatched groups. *P < 0.05, ***P < 0.001.
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acute disease. With respect to adaptive immunity (Figure 3B), surface expression of BAFF, a critical regulator 
of B cell maturation and survival, was increased on intermediate monocytes during acute malaria. Programmed 
death-ligand 1 (PD-L1), which delivers inhibitory signals upon binding to its receptor on T cells, had increased 
expression on intermediate monocytes during acute malaria. CD86 delivers costimulatory signals needed for T 
cell activation, and while CD86 expression was increased on intermediate monocytes during acute disease, its 
expression was significantly decreased on both the classical and nonclassical subsets. Increased ratios of PD-L1/
CD86 expression on intermediate monocytes have been described in individuals with chronic hepatitis C infec-
tion and were associated with increased viremia and impaired antiviral functions (33). The ratio of PD-L1/
CD86 expression was increased on all monocyte subsets during acute malaria compared with 6-week recovery 
samples and samples from healthy children (Figure 4).
We also compared monocyte subset proportions and innate and adaptive immunity phenotypic mark-
ers of  healthy control children with asymptomatic parasitemia versus those who were asymptomatic with 
no P. falciparum infection detectable by blood smear or PCR. While monocyte subset proportions were 
similar between children with asymptomatic infection and those who were uninfected (Supplemental Fig-
ure 2), children with asymptomatic infection had altered expression of  TLR4, CD36, BAFF, and CD86 on 
monocyte subsets compared with uninfected children (Supplemental Figure 3).
Monocyte phagocytic function during symptomatic and asymptomatic infection. We assessed both nonopsonic 
and opsonic phagocytic activity of  the participants’ monocytes during acute malaria compared with that 6 
weeks following treatment. Peripheral blood mononuclear cells (PBMCs) were incubated with plasma-op-
sonized CFSE-labeled IEs, and phagocytosis by monocytes was quantified by flow cytometry. When IEs were 
opsonized with heat-inactivated North American plasma, monocyte phagocytic activity was presumed to 
comprise primarily nonopsonic phagocytosis, as complement is inactivated by heat and malaria-naive North 
American plasma does not contain IE-specific antibodies. When IEs were opsonized with heat-inactivated 
pooled plasma from malaria-immune Kenyan adults, monocyte phagocytic activity was presumed to repre-
sent primarily IE-specific IgG-mediated opsonic phagocytosis. Adults living in this area of  western Kenya 
have high levels of  antibodies specific for P. falciparum variant surface antigens (VSAs) expressed on the sur-
face of  IEs, including VSAs expressed by the Ghana14 isolate used in phagocytosis assays (Supplemental 
Figure 4A). Because phagocytosis assays show day-to-day experimental variation (generally due to small vari-
ations in magnet purification of  IEs), all assays were performed in parallel with North American malaria-na-
ive PBMCs (from a single donor) run alongside each acute-recovery PBMC pair (Supplemental Figure 4, B 
and C). Each acute-recovery pair was run in the same-day assay, so comparisons were made of  phagocytic 
function between acute-recovery pairs but not of  absolute differences in phagocytosis among individuals.
Opsonic phagocytic activity of  all monocytes was decreased during acute malaria compared with that 6 
weeks after treatment (median values 29.8% phagocytosis vs. 43.8%, P = 0.02, n = 12 pairs; Figure 5A). These 
results appear to be driven by 6 acute-recovery pairs of  children who were uninfected (P. falciparum PCR 
negative) at recovery (23.6% phagocytosis during acute malaria vs. 40.2% upon recovery, P = 0.03; Figure 
5B), as there was no difference in monocyte opsonic phagocytic function between acute malaria and recovery 
samples from the 6 children who had asymptomatic infection at recovery (40.8% vs. 46.1% respectively, P = 
0.56; Figure 5C). There was no statistically significant difference in nonopsonic phagocytosis between acute 
malaria and recovery samples from all 12 children (4.7% vs. 6.2%, P = 0.24; Figure 5D). A small decrease in 
nonopsonic phagocytic function during acute malaria compared with recovery was also noted in acute-recov-
ery pairs of  children who were uninfected at recovery (4.5% vs. 7.2%, P = 0.03; Figure 5E). As with opsonic 
phagocytic function, there was no difference in monocyte nonopsonic phagocytic function between acute 
malaria and recovery in children who had asymptomatic infection at recovery (6.2% vs. 5.6%, P = 0.44; Fig-
ure 5F). Taken together, these data show that P. falciparum infection causing uncomplicated malaria disease as 
well as asymptomatic parasitemia is associated with impaired monocyte phagocytosis of  IEs.
Figure 3. Cell surface phenotypes of monocyte subsets are activated during acute uncomplicated malaria. Flow cytometry was used to determine cell 
surface expression of 6 markers on the three monocyte subsets (classical, intermediate, and nonclassical) for samples from cases of acute malaria, 6-week 
recovery samples (n = 23 pairs), and samples from healthy child controls (n = 17). (A) Cell surface expression of markers important in innate immunity: 
TLR2, TLR4, and CD36. (B) Cell surface expression of markers important in adaptive immunity: BAFF, PD-L1, and CD86. Wilcoxon matched-pairs rank test 
was used to compare acute malaria samples to 6-week recovery samples. Kruskal-Wallis test was used to compare healthy child samples to acute malaria 
and 6-week recovery samples. Bars represent the median values with interquartile ranges. *P < 0.05, **P < 0.01, ***P < 0.001, ****P < 0.0001. iMFI, inte-
grated mean fluorescence intensity; BAFF, B cell–activating factor; PD-L1, programmed death-ligand 1.
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IE phagocytosis by monocyte subsets. Differences in phagocytic function were analyzed across the three 
monocyte subsets within a given individual at the time of  presentation with and recovery from acute malar-
ia. During acute malaria, both intermediate and nonclassical monocytes displayed greater opsonic phago-
cytic activity compared with classical monocytes (48.1% and 53.6% vs. 26.4%, P < 0.01; Figure 6A). Similar 
patterns were seen for monocytes from 6-week recovery samples: nonclassical monocytes displayed greater 
opsonic phagocytic activity compared with classical monocytes (66% vs. 34.6%, P = 0.003; Figure 6A).
Nonopsonic phagocytic activity was also greater in the intermediate and nonclassical subsets. During 
acute malaria, intermediate and nonclassical monocytes displayed greater nonopsonic phagocytic activity 
compared with classical monocytes (7.6% and 6.7% vs. 4.5%, P < 0.05; Figure 6B). Similar patterns were 
seen 6 weeks following treatment, in which intermediate and nonclassical monocytes had greater nonopson-
ic phagocytic function compared with classical monocytes (14% and 10.3% vs. 4.9%, P < 0.05; Figure 6B). 
These patterns of  differential phagocytic function among the monocyte subsets were similar in children who 
were uninfected at recovery and those with asymptomatic parasitemia at recovery (Figure 6, C–F).
Monocyte cytokine responsiveness to TLR ligands during acute malaria and upon recovery. Monocyte cytokine 
production was analyzed using negatively selected monocytes isolated from fresh venous blood samples from 
children presenting with acute malaria and 6 weeks following treatment. Freshly isolated monocytes from 
malaria-naive North American adults were used as experimental controls. Isolated monocytes were cultured 
for 18 hours, and constitutive cytokine production (media alone) was compared with stimulation with a 
TLR4 agonist (LPS) and a TLR2/TLR1 agonist (Pam3CSK4 [P3C]). Monocytes from both acute malaria 
and recovery visits were highly responsive to stimulation with LPS and P3C, without signs of  innate immune 
tolerance. For example, monocytes from acute malaria cases showed an over 300-fold increase in IL-6 produc-
tion and an over 100-fold increase in TNF production after stimulation with LPS. A similar effect was seen 
for 6-week recovery monocytes, with a 90-fold increase in IL-6 and an over 100-fold increase in TNF after 
LPS stimulation (Figure 7). There were no statistically significant differences in cytokine responses to LPS or 
P3C between acute and recovery monocytes (the only statistically significant difference between acute malaria 
and recovery monocytes was in constitutive production of  IL-12p40) (Figure 7). Half  of  these children had 
asymptomatic parasitemia at their 6-week recovery visit. TLR responses were not different between those 
who remained uninfected (P. falciparum PCR negative) at 6 weeks and those with asymptomatic parasitemia 
(blood smear or PCR positive) (Supplemental Figure 5).
Monocytes from healthy malaria-naive North Americans were included as experimental controls (repre-
senting nontolerant monocytes) to ensure that the assay worked. In this regard, it is notable that monocytes 
from Kenyan children during acute malaria and upon recovery showed greater magnitude of  proinflamma-
tory cytokine production in response to stimulation with TLR ligands than did healthy North American 
monocytes, particularly for IL-6, IL-12p40, and TNF (Figure 7). Collectively, these data show no evidence for 
Figure 4. Acute uncomplicated malaria is associated with an increased PD-L1/CD86 ratio on all monocyte subsets. Ratios of cell surface expression 
of PD-L1/CD86 on the (A) classical, (B) intermediate, and (C) nonclassical monocyte subsets for samples from cases of acute malaria, 6-week recovery 
samples (n = 23 pairs), and samples from healthy child controls (n = 17) are indicated on the y axes. Bars represent the median values with interquartile 
ranges. Wilcoxon matched-pairs rank test was used to compare acute malaria samples to 6-week recovery samples. Kruskal-Wallis test was used to 
compare healthy children to acute malaria samples and 6-week recovery samples. **P < 0.01, ***P < 0.001, ****P < 0.0001. iMFI, integrated mean 
fluorescence intensity; PD-L1, programmed death-ligand 1.
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monocyte tolerance during or after recovery from acute malaria and, in fact, 
suggest that monocytes from these children are primed to respond to TLR4 
and TLR2/TLR1 ligands independent of  P. falciparum infection status.
Monocyte gene expression profiles during acute malaria and upon recov-
ery. Using a targeted panel for digital RNA sequencing, we characterized 
inflammatory gene expression profiles of  monocytes isolated from six 
children during acute malaria and their matching samples 6 weeks fol-
lowing treatment. All of  these children were P. falciparum PCR negative 
at 6 weeks. Targeted analysis of  508 genes involved in inflammation and 
immunity identified 125 differentially expressed genes (51 overexpressed 
and 74 underexpressed; P < 0.05) during malaria compared with monocytes 
obtained 6 weeks after treatment. The heatmap in Figure 8A illustrates key 
genes that were differentially expressed during acute malaria compared 
with recovery. Monocyte genes overexpressed during acute malaria includ-
ed several important inflammatory genes, including complement proteins 
and genes involved in TLR signaling (TLR8, LY96, MYD88). Expression of  
Epstein-Barr virus induced 3 (EBI3) was increased approximately 30-fold 
(P < 0.0001) during acute malaria relative to recovery. EBI3 encodes the 
IL-27 β subunit of  the cytokines IL-27, which has both proinflammatory 
and antiinflammatory roles in regulating cell-mediated immunity (34), and 
IL-35, an antiinflammatory cytokine important in Treg function (35, 36). 
Notably, monocytes during acute malaria also underexpressed several genes 
involved in the inflammatory response and chemotaxis, including numer-
ous chemokines and chemokine receptors, genes important to T cell activation (CD86, CIITA, CTLA4), and 
transcriptional regulators of  the inflammatory response (STAT4, REL, HIF1A). These data indicate that, by 
the time these patients present to the clinic with fever and other symptoms of  uncomplicated malaria, their 
monocytes may have already started to downregulate an initial proinflammatory response.
Pathway enrichment analysis of  the genes overexpressed during acute malaria compared with 
recovery revealed significant enrichment in two Kyoto Encyclopedia of  Genes and Genomes path-
ways: “Fc gamma receptor mediated phagocytosis” (P = 0.0007, 7 genes) and “Staphylococcus aureus 
infection” (P = 0.002, 9 genes) (Supplemental Table 4). Interestingly, genes for several proinflam-
matory mediators (including IL-1β, IL-6, IL-8, and TNF) were not differentially expressed between 
acute malaria and recovery, even though plasma cytokine profiles revealed a robust proinflammato-
ry cytokine response during acute disease. The heatmap in Figure 8B illustrates several important 
inflammatory genes that were not differentially expressed by monocytes between acute and recovery 
but were significantly different from monocytes from healthy North American malaria-naive controls 
Figure 5. Monocytes display decreased phagocytic function during P. falci-
parum infection. (A) Opsonic phagocytic function of all monocytes from acute 
malaria (AM) and 6-week recovery PBMC samples (n = 12 pairs) in the presence 
of Ghana14 IEs opsonized with heat-inactivated pooled plasma from Kenyan 
adults. (B) Opsonic phagocytic function of all monocytes from AM and 6-week 
PBMC samples (n = 6 pairs) from a subset of children who were P. falciparum PCR 
negative at 6-week follow up. (C) Opsonic phagocytic function of all monocytes 
from AM and 6-week PBMC samples (n = 6 pairs) from a subset of children with 
asymptomatic P. falciparum infection at 6-week follow up (defined by positive 
blood smear or P. falciparum PCR). (D) Nonopsonic phagocytic function of all 
monocytes from AM and 6-week PBMC samples (n = 12 pairs) in the presence of 
Ghana14 IEs opsonized with heat-inactivated plasma from a malaria-naive North 
American. (E) Nonopsonic phagocytic function of all monocytes from AM and 
6-week PBMC samples (n = 6 pairs) from a subset of children who were P. falci-
parum PCR negative at 6-week follow up. (F) Nonopsonic phagocytic function of 
all monocytes from AM and 6-week PBMC samples (n = 6 pairs) from a subset of 
children with asymptomatic P. falciparum infection at 6-week follow up (defined 
by positive blood smear or P. falciparum PCR). Wilcoxon matched-pairs rank test 
was used to compare AM to 6-week recovery samples. Data are shown as medi-
ans with interquartile ranges. *P < 0.05.
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(P < 0.05). Of  the 508 genes analyzed, 114 were overexpressed and 86 underexpressed during acute 
malaria compared with North American controls; 124 were overexpressed and 95 underexpressed at 
the 6-week recovery visit compared with North American controls (P < 0.05). There was substantial 
overlap for these differentially expressed genes, as 75 genes were overexpressed for both acute malar-
ia and 6-week recovery monocytes compared with North American controls. These gene expression 
data suggest that monocytes from these children (during acute malaria and in a healthy state) are 
tightly regulated and primed for an inflammatory response. This is consistent with our results show-
ing that monocytes are equally responsive to TLR stimulation during acute malaria as upon recovery 
Figure 6. Intermediate and nonclassical monocytes display greater phagocytic function compared with classical monocytes. (A) Opsonic phago-
cytic function of the three monocyte subsets from acute malaria (AM) and 6-week recovery PBMC samples (n = 12 pairs) in the presence of Ghana14 
IEs opsonized with heat-inactivated pooled plasma from malaria-immune Kenyan adults. (B) Nonopsonic phagocytic function of monocyte subsets 
from AM and 6-week PBMC samples (n = 12 pairs) in the presence of Ghana14 IEs opsonized with heat-inactivated plasma from a malaria-naive North 
American. (C) Opsonic phagocytic function of monocyte subsets from AM and 6-week PBMC samples (n = 6 pairs) from a subset of children who 
were P. falciparum PCR negative at 6 weeks. (D) Nonopsonic phagocytic function of monocyte subsets from AM and 6-week PBMC samples (n = 6 
pairs) from a subset of children who were P. falciparum PCR negative at 6 weeks. (E) Opsonic phagocytic function of monocyte subsets from AM and 
6-week PBMC samples (n = 6 pairs) from a subset of children with asymptomatic P. falciparum infection at 6 weeks (defined by positive blood smear 
or P. falciparum PCR). (F) Nonopsonic phagocytic function of monocyte subsets from AM and 6-week PBMC samples (n = 6 pairs) from a subset of 
children with asymptomatic P. falciparum infection at 6 weeks (defined by positive blood smear or P. falciparum PCR). Differences between AM and 
6-week PBMC samples analyzed by Wilcoxon matched-pairs rank test. Differences among subsets analyzed by Friedman test with multiple compari-
sons. Data shown are medians with interquartile ranges. *P < 0.05, **P < 0.01, ****P < 0.0001.
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(with enhanced TLR responses relative to malaria-naive monocyte controls). Of  note, gene expression 
profiles of  individual monocyte subsets were not analyzed separately due to the limited number of  
PBMCs obtained from these pediatric patients.
Discussion
We demonstrate in this report significant changes in monocyte phenotypes and functions associated with 
symptomatic and asymptomatic P. falciparum infection of  Kenyan children living in a malaria endem-
ic area. During uncomplicated malaria, an expansion of  the inflammatory intermediate CD14++CD16+ 
monocyte subset was coupled with acutely activated monocyte phenotypes. Impairment in monocyte 
phagocytic function was associated with both symptomatic and asymptomatic P. falciparum infection. 
Freshly isolated monocytes from both acute and recovery time points demonstrated primed TLR responses. 
Monocyte transcriptional profiles reflected a tightly regulated response during uncomplicated malaria com-
pared with recovery, with balanced proinflammatory and antiinflammatory gene expression. In addition, 
several inflammatory genes that were expressed equally by acute and recovery monocytes had significantly 
increased expression when compared with healthy malaria-naive controls, consistent with our functional 
data showing primed TLR responses at both acute and recovery time points.
Innate immune activation plays a crucial role in host protection as well as pathogenesis during malar-
ia infection. Dynamic shifts in monocyte subpopulations occur during symptomatic malaria, and each 
monocyte subset is characterized by different stages of  differentiation with distinct gene expression profiles, 
phenotypes, and physiologic functions (22, 37). Our results are similar to those in which Ogonda et al. 
found an expansion in the intermediate CD14++CD16+ subset in cases of  both uncomplicated and severe 
malaria in children from western Kenya (27). The dynamics of  circulating human monocyte subsets were 
recently studied using in vivo deuterium labeling, and experimental endotoxemia led to a transient but 
profound monocytopenia with restoration of  circulating monocytes through release of  classical mono-
cytes from the bone marrow; classical monocytes were shown to give rise to intermediate and nonclassical 
Figure 7. Monocytes from children during acute malaria and 6 weeks following treatment are highly responsive to stimulation with TLR ligands. Mono-
cytes were negatively selected from fresh venous blood samples from children during acute malaria and 6 weeks following treatment (n = 8 pairs). Healthy 
North American (N. Amer.) adult controls (n = 4) were used as experimental controls. All assays were performed with technical duplicates. Cells were 
cultured for 18 hours with media alone, 10 ng/ml LPS, or 100 ng/ml Pam3CSK4 (P3C), and cytokine concentrations were measured in culture supernatants. 
Wilcoxon matched-pairs rank test was used to compare acute malaria to 6-week recovery samples. Kruskal-Wallis test was used to compare acute malar-
ia, 6-week recovery, and N. Amer. control samples. Data are shown as medians with interquartile ranges. *P < 0.05, **P < 0.01, as compared with controls.
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monocytes in the periphery (38). During malaria, systemic inflammatory factors as well as local factors 
in the bone marrow may provide signals that lead to an increased percentage of  classical monocytes that 
transition into intermediate (and ultimately nonclassical) monocytes (39). Increased proportions of  inflam-
matory monocyte subpopulations may be beneficial to the host via enhanced antiparasitic functions. Strong 
antibody-dependent cellular inhibition activity was noted in a distinct CD16+ subpopulation of  monocytes 
in Thai adults with falciparum malaria (26). In our study, CD16+ intermediate and nonclassical monocytes 
had greater phagocytosis of  IEs compared with the classical subset. Similarly, Antonelli et al. have shown 
superior phagocytosis of  Plasmodium vivax–infected reticulocytes by the intermediate subset (28).
Figure 8. Monocytes from children with uncomplicated malaria 
have a distinct, regulated inflammatory gene expression profile. 
Targeted digital RNA sequencing was performed on monocytes 
isolated from cryopreserved PBMCs via negative selection over a 
magnetic column. A customized panel targeted 508 genes import-
ant in inflammation and immunity (QIAseq Human Inflammation 
and Immunity Transcriptome Panel, Qiagen). Differential expres-
sion was determined using the DESeq2 R/Bioconductor package. 
(A) Monocyte transcriptional profiles were compared between 
samples from cases of acute malaria and matching 6-week 
recovery samples (n = 6 pairs). Of the 508 genes analyzed, 125 
were differentially expressed between AM and 6-week recovery 
(51 overexpressed and 74 underexpressed during AM; P < 0.05). 
Key genes are listed in the heatmap. (B) Monocyte transcriptional 
profiles were compared among samples from children with acute 
malaria, 6-week recovery samples (n = 6 pairs), and samples from 
healthy malaria-naive North American controls (n = 5). Of the 508 
genes analyzed, 114 were overexpressed and 86 underexpressed 
during acute malaria compared with North American controls and 
124 were overexpressed and 95 underexpressed at 6-week recov-
ery compared with North American (N. Amer.) controls (P < 0.05). 
Key genes are listed in the heatmap. None of the genes listed in B 
were differentially expressed between acute malaria and recovery.
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Here, we showed that uncomplicated malaria in children was associated with monocyte activation in 
the context of  significant systemic inflammation. Plasma levels of  IL-10 and TNF were markedly elevated, 
and IL-10, TNF, and IL-6 positively correlated with PfHRP2 levels, while IL-12p70 and IFN-γ negatively 
correlated with PfHRP2 levels. Luty et al. found remarkably similar correlations with parasitemia and 
plasma IL-10, TNF, and IL-12p70 levels among Gabonese children with uncomplicated and severe malaria 
(40). Weinberg et al. also demonstrated similarly elevated plasma levels of  IL-10 in Tanzanian children 
with moderately severe and severe malaria, with IL-10 levels showing a significant correlation with disease 
severity as well as monocyte polarization toward an M2 phenotype with high levels of  arginase 1 and low 
levels of  NOS2 expression (which may contribute to NO insufficiency and oxidative stress) (41). Collective-
ly, these observations suggest that oxidative stress related to heme and/or hemozoin toxicity to phagocytes 
may enhance IL-10 production while downregulating IL-12 activity (42).
We also demonstrated that asymptomatic parasitemia was associated with impaired monocyte phagocy-
tosis, altered monocyte surface phenotypes, and elevated levels of  inflammatory cytokines and acute-phase 
reactants. These systemic inflammatory factors are likely produced by several different cell types, including 
monocytes, neutrophils, and dendritic cells. The level of  inflammation appears to be dependent on the densi-
ty of  blood-stage infection and, by inference, P. falciparum biomass, as children with asymptomatic infection 
detectable by blood smear had higher levels of  inflammation compared with uninfected children as well 
as children who were P. falciparum PCR positive but blood smear negative. Others have shown an associ-
ation of  asymptomatic P. falciparum infection in children with increased proportions of  circulating CD16+ 
monocytes (43), anemia, and increased markers of  systemic inflammation (44). Impaired phagocytosis by 
dendritic cells has been associated with submicroscopic parasitemia in malaria-naive adult volunteers exper-
imentally challenged with P. falciparum–IEs (45). These data lend support to the assessment that the term 
“asymptomatic parasitemia” is inaccurate and should instead be referred to as “chronic malaria infection,” 
given the detrimental effects that even low-density infections may have on innate immune functions and 
individual health and development (in addition to serious societal and public health concerns) (46, 47).
Impairment in monocyte phagocytosis was observed across the clinical spectrum of  P. falciparum 
infection in this cohort, and further research is required to elucidate the underlying mechanisms. Previous 
monocyte phagocytosis of  IEs in vivo is likely to impair the phagocytic capacity of  these cells ex vivo. 
Schwarzer et al. have shown that ingestion of  hemozoin impairs the ability of  adherent monocytes to 
repeat phagocytosis (48). Plasmodium parasites might also employ mechanisms to directly manipulate the 
host cytoskeleton and evade phagocytosis (49). Intravascular hemolysis during malaria infection leads to 
release of  the heme moiety from extracellular hemoglobin, and we speculate that heme toxicity contributes 
to impaired monocyte phagocytosis of  IEs. This notion is supported by recent work by Martins et al., in 
which they demonstrate that heme inhibits phagocyte function directly by disrupting the actin cytoskeleton 
via interactions with DOCK8 and Cdc42 (50). In addition, increasingly impaired neutrophil phagocytosis 
of  Salmonella was associated with increasingly severe hemolysis during malaria in Gambian children (51).
Another possible mechanism for impaired phagocytosis involves increased signaling through the inhib-
itory CD47 pathway. Recently, Ayi et al. showed that CD47-SIRPα interactions negatively regulate macro-
phage phagocytosis of  IEs, and CD47 deficiency was associated with improved survival in a murine model 
of  cerebral malaria (52). Our targeted transcriptional analysis revealed increased expression of  CD47 as 
well as enrichment in the “Fc gamma receptor mediated phagocytosis” pathway during acute malaria com-
pared with recovery. Several genes in the FcγR-mediated phagocytosis pathway were overexpressed during 
acute malaria, including CDC42 and genes for the activating FcγRs (FCGR1A, FCGR3A). A limitation of  
our targeted analysis is that expression of  some key inhibitory genes in this pathway were not measured 
(including the inhibitory FcγR, FCGR2B, and the downstream phosphatase SHIP, responsible for negative 
regulation of  phagocytosis, ref. 53). We hypothesize that, as part of  the regulated inflammatory response 
that occurs during uncomplicated malaria, inhibitory receptors are upregulated to control inflammation, 
and as a result, lead to decreased phagocytic capacity.
Monocyte activation in response to an infectious insult is generally described as a polarization toward 
either a tolerant or a primed phenotype. Monocyte/macrophage tolerance is well described in patients with 
bacterial sepsis (54, 55) and in animal and in vitro models of  LPS hyporesponsiveness (56, 57). Endotoxin 
tolerance was initially defined as a transient unresponsive state in which cells previously exposed to endo-
toxin are unable to respond to repeat challenge with endotoxin (primarily measured by a decreased ability to 
produce proinflammatory cytokines) (58). Monocyte tolerance is now more accurately and comprehensively 
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described as a reprogramming or modulation of  cellular responses, rather than as global suppression or 
exhaustion (59). Several studies have shown that although tolerant human monocytes have reduced pro-
duction of  TNF and IL-6 after LPS rechallenge, along with impaired antigen presentation, these cells have 
enhanced or preserved antimicrobial functions, including phagocytosis, reactive oxygen species production, 
and tissue remodeling (60–62). Transcriptome studies in monocytes/macrophages have revealed distinct 
genetic signatures associated with endotoxin tolerance (57, 60). Shalova et al. studied transcriptome profiles 
of  monocytes from adults with Gram-negative urosepsis and showed an overexpression of  a large number of  
proinflammatory genes when compared with monocytes obtained after clinical recovery, including several 
chemokines (CCL2, CCL7), proinflammatory cytokines (IL1B, IL6), and transcription factors (HIF1A, STAT4) 
(62). In contrast to the functional changes characteristic of  monocyte tolerance, monocytes from children 
with uncomplicated malaria showed enhanced proinflammatory cytokine production and decreased phago-
cytosis. Transcriptional profiles of  monocytes during acute malaria were in several ways distinct from those 
of  tolerant monocytes from sepsis patients. For example, acute malaria was associated with underexpression 
of  the chemokines CCL2 and CCL7; no change in expression of  proinflammatory cytokines, such as IL1B 
and IL6; and underexpression of  the transcription factors HIF1A and STAT4. It is important to take into 
account the underlying health status and previous exposures of  these patients when analyzing differences 
between acute disease and recovery. Notably, monocyte expression of  a number of  proinflammatory genes 
(including IL1B, IL6, and TNF) was not different between acute malaria and recovery, though these genes 
were significantly overexpressed at both time points when compared with healthy malaria-naive controls. 
Taken together, these results suggest that, during uncomplicated malaria infection in children from endemic 
areas, monocytes undergo modulations of  both proinflammatory and antiinflammatory functions, with a 
priming effect on innate immune responses that is observed several weeks after clinical recovery.
In contrast to tolerant monocytes, primed (or “trained”) monocytes display enhanced proinflamma-
tory cytokine production when challenged with a secondary stimulus (63). Our results are consistent with 
recent reports that demonstrated evidence for a priming effect on the innate immune response during P. 
falciparum infection. Using an experimental human malaria model, McCall et al. showed primed TLR4 and 
TLR2/TLR1 responses during subpatent blood-stage infection that then normalized after curative treatment 
(these in vivo findings were supported by an in vitro model of  PBMC priming by P. falciparum antigens) (64). 
Franklin et al. demonstrated primed innate responses (to several TLR ligands, including TLR4 and TLR2) of  
PBMCs from Brazilian adults with uncomplicated falciparum malaria, with more robust proinflammatory 
cytokine responses than that observed in the experimental malaria volunteers (65). As with the volunteers, 
TLR responses in the Brazilian adults reversed after treatment. In our cohort, we did not observe a reversal 
in enhanced TLR responses after treatment, which may be due to differences in age, duration of  infection, 
and transmission intensity. Frequent episodes of  clinical malaria (among other potential infectious and envi-
ronmental stimuli) may have a priming/training effect on monocytes that persists for several weeks in these 
children. Increased extracellular heme and proinflammatory cytokines, such as IP-10, associated with mouse 
malaria models and human P. falciparum infections have also been reported to increase expression of  TLRs, 
such as TLR4, on the surface of  monocyte/macrophages and circulating endothelial progenitor cells (66).
A limitation of  our study is the potential influence that unmeasured confounders, including infec-
tious, genetic, and environmental factors, may have on monocyte functions. However, the study design with 
acute malaria and matching recovery samples allowed each participant to serve as his/her own control and 
thus strengthens support for our conclusions that P. falciparum infection leads to modulations of  monocyte 
functions. Another limitation is the absence of  additional longitudinal samples (including those obtained 
prior to acute malaria episodes) that could provide more definitive data regarding the priming effect that 
acute malaria has on monocyte TLR responsiveness. Future prospective studies incorporating further lon-
gitudinal measurements, along with detailed measures of  exposure to malaria as well as other infections, 
will provide crucial information regarding the relationship between innate immune responses and clinical 
immunity to malaria.
Malaria-induced modulation of  monocyte functions likely has several important implications for the 
host. A general impairment in monocyte phagocytosis may contribute to increased susceptibility to inva-
sive bacterial infections, a known complication of  malaria in children (67–69). Impairment in neutrophil 
killing of  nontyphoidal Salmonella has been observed following uncomplicated falciparum malaria in 
African children (51), but this impairment is related to defects in oxidative killing due to malaria-induced 
changes in heme-oxygenase 1 expression during myeloid cell development and not to phagocytosis. 
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Priming of  monocytes could be deleterious to the host if  the systemic inflammatory response to subse-
quent TLR stimulation (by malaria or other pathogens) proceeds unchecked, driving the pathogenesis 
of  severe infection (70). On the other hand, enhanced innate immune responses might aid in control 
of  parasitemia, provide nonspecific antimicrobial protection, and augment vaccine responsiveness (63). 
Repeated activation of  innate immune responses by recurring P. falciparum infections may play a key role 
in developing and maintaining clinical immunity to malaria. Further study is needed to fully define how 
modulated monocyte functions effect disease severity and the acquisition of  antimalarial immunity in 
children from endemic areas.
Methods
Study site and study participants. The study was conducted at the Chulaimbo Sub-District Hospital out-
patient clinic in Kisumu County, Kenya. The clinic is located approximately 10 kilometers from the 
research laboratory at the Kenya Medical Research Institute research station in Kisian. Malaria trans-
mission in this area is perennially high, with peaks coinciding with seasonal rains in May–July and 
October–November (31, 71). The study population was almost exclusively of  the Luo ethnicity. P. falci-
parum is the primary malaria parasite species (72).
Participants were enrolled in this observational cohort between June 2013 and April 2016; they includ-
ed children aged 1–10 years with acute uncomplicated malaria diagnosed by light microscopy, healthy 
asymptomatic children aged 1–10 years, and healthy asymptomatic adults aged 18 years or older residing in 
location-matched areas. All cases of  uncomplicated malaria were febrile (temperature ≥37.5°C) and with-
out signs or symptoms of  severe malaria. All healthy children and adult community controls were asymp-
tomatic and afebrile at enrollment and denied any episodes of  febrile malaria or receipt of  antimalarials in 
the 2 months preceding enrollment. Thick and thin blood smears were prepared from all blood samples. A 
slide was deemed negative when no parasites were seen after counting microscopic fields containing at least 
200 leukocytes. The number of  parasites per μl of  blood was calculated based on each participant’s total 
leukocyte count. Children with acute uncomplicated malaria were treated with artemether-lumefantrine 
per Kenyan Ministry of  Health guidelines and followed up at 2 and 6 weeks. At 2 weeks, finger prick blood 
samples were obtained for blood smear to ensure parasite clearance. Venous blood samples were obtained 
from cases with acute malaria at the time of  presentation (before administration of  the first dose of  arte-
mether-lumefantrine) and 6 weeks following treatment and from healthy controls at enrollment.
Malaria diagnostics and related laboratory tests. Submicroscopic blood-stage infections were detected by con-
ventional PCR of  DNA samples from 6-week recovery visits and healthy control enrollment visits. A nested 
PCR assay targeting P. falciparum–specific small subunit ribosomal RNA genes was performed as previously 
described; the limit of  detection for the assay is 6 parasites/μl blood (73). For cases of  acute uncomplicated 
malaria, PfHRP2 levels in the plasma were determined using a commercial ELISA kit according to the man-
ufacturer’s instructions (Malaria Ag CELISA, Cellabs Pty. Ltd.). Extracellular heme levels were measured in 
plasma samples using a colorimetric assay that measures hemin, an oxidized form of  heme (Biovision). The 
lower limit of  detection was 1.03 μM. Blood leukocyte differentials and total leukocyte counts and routine 
hematological variables were measured using an automated cell counting machine (Beckman Coulter).
Indicators of  systemic inflammation. We measured levels of  16 cytokines and acute-phase reactants in plas-
ma samples from 60 children with acute malaria, the same 60 children 6 weeks following treatment, and 40 
healthy child controls. All plasma samples were assayed immediately after initial thawing. A multiplexed 
bead-based immunoassay was used to simultaneously measure IFN-γ, TNF, IP-10, IL-10, IL-6, IL-7, IL-9, 
IL-17, IL-12p40, IL-12p70, IL-4, sTNF-R1, and sTNF-R2 (Millipore). Levels of  CRP, soluble BAFF, and 
soluble CD14 were determined using commercial ELISA kits (R&D Systems).
Monocyte subset phenotypes by flow cytometry. PBMCs were separated by Ficoll-Hypaque density gradient 
centrifugation and cryopreserved as previously described (74). Cryopreservation did not have a significant 
effect on proportions of  monocyte subsets (Supplemental Figure 6), as has been shown by others previously 
(75). PBMCs were gently thawed and resuspended at a concentration of  106 cells/ml in RPMI-1640 (GIB-
CO). LIVE/DEAD Fixable Violet stain was used to assess cell viability (ThermoFisher Scientific). PBMCs 
were directly stained for 20 minutes at 4°C with a combination of  fluorochrome-conjugated monoclonal 
antibodies, including Alexa Fluor 700–labeled anti-CD14 (clone 61D3; eBioscience), APC-Cy 7–labeled 
anti-CD16 (clone 3G8; BioLegend), FITC-labeled anti-CD282 TLR2 (clone TL2.1; BioLegend), PE-labeled 
anti-CD284 TLR4 (clone HTA125; BioLegend), PerCP-labeled anti-CD36 (clone AC106; Miltenyi Biotec), 
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PE-labeled anti-CD257 BAFF (clone T7-241; BioLegend), APC-labeled anti-CD274 PD-L1 (clone 29E.2A3; 
BioLegend), and PE-CF594-labeled anti-CD86 (clone 2331; BD Biosciences). The stained cells were washed 
twice, centrifuged at 320 g for 10 minutes, resuspended in 100 μl of  fixing solution (2% paraformaldehyde 
kept on ice), and subjected to flow analysis using an LSRII flow cytometer (BD Biosciences). FlowJo soft-
ware (Tree Star) was used for data analysis. The gating strategy put forth by the Nomenclature Committee 
of  the International Union of  Immunological Societies was used to determine proportions of  monocyte sub-
sets (classical CD14++CD16–, intermediate CD14++CD16+, and nonclassical CD14+CD16++) (21). Integrated 
mean fluorescence intensity values were calculated for each cell surface marker by multiplying the geometric 
mean fluorescence by the frequency of  the parent population.
Opsonic and nonopsonic phagocytosis assays. Asexual-stage P. falciparum parasite cultures were maintained 
in group O human erythrocytes at 4% hematocrit in RPMI-1640-HEPES medium supplemented with 5% 
heat-inactivated group AB human serum and 5% Albumax (GIBCO), at 37°C with 5% CO2, 5% O2, and 
90% N2. Parasite cultures were enriched for knob-expressing strains using 0.75% gelatin sedimentation 
every 2 weeks. Cultures were checked for Mycoplasma contamination every 2–4 weeks using PCR (Sig-
ma-Aldrich). IEs at the trophozoite stage were concentrated to >75% purity by magnetic separation using 
MACS LS Columns (Miltenyi Biotec). IEs were labeled with 50 μM CFSE (CellTrace CFSE, ThermoFish-
er Scientific) at 1 × 108 cells/ml for 10 minutes at 37°C. CFSE-labeled IEs were opsonized with heat-inacti-
vated plasma (at a final plasma concentration of  1:10) for 1 hour and then washed in RPMI-1640. Plasma 
from malaria-naive North Americans was used as a negative control, and pooled plasma from 8 malar-
ia-immune Kenyan adults was used as a positive control. These assays utilized IEs from the P. falciparum 
isolate Ghana14, described in this study. The Ghana14 isolate originated from the peripheral blood of  a 
child with severe malaria returning to the USA from Ghana (year 2014) and was adapted to in vitro culture 
over several weeks. We used the Ghana14 isolate because experiments comparing phagocytosis by North 
American monocytes of  the widely used reference isolate 3D7 versus Ghana14 showed the same patterns 
among the subsets but greater magnitude with Ghana14 (Supplemental Figure 7).
Opsonized CFSE-labeled IEs (concentration 108 cells/ml) were incubated with thawed cryopreserved 
PBMCs (concentration 2 × 106 cells/ml) at a 10:1 ratio of  IE/PBMCs in cell culture medium (RPMI-1640 
with 2 mM L-glutamine, 10% FBS, 10 mM HEPES, 1 mM sodium pyruvate, 4.5 g/l glucose, 1.5 g/l sodi-
um bicarbonate, and 0.05 mM 2-ME). The cells were incubated in polypropylene tubes for 40 minutes at 
37°C, in 5% CO2, on an orbital shaker. After the phagocytosis incubation, the cells were placed on ice and 
washed in PBS, and LIVE/DEAD Fixable Violet stain was used to assess cell viability. PBMCs were direct-
ly stained for 20 minutes at 4°C with Alexa Fluor 700–labeled anti-CD14 (clone 61D3; eBioscience) and 
APC-Cy 7–labeled anti-CD16 (clone 3G8; BioLegend). Erythrocytes were lysed and leukocytes were fixed 
using 1-Step Fix/Lyse Solution (BioLegend). Cells were subjected to flow analysis using an LSRII flow 
cytometer (BD Biosciences). The percentage of  monocytes within a population that had phagocytosed IEs 
was calculated according the CFSE fluorescence. A universal gate for CFSE positivity was set according to 
the signal from lysed IEs (all positive for CFSE) and from lymphocytes (all negative for CFSE).
Phagocytosis assays measured phagocytic function of  monocyte subsets in PBMC samples from 
12 children with acute malaria and their matching 6-week recovery samples (a single North American 
PBMC donor was run alongside each assay as a control). Six of  the twelve participants were P. falciparum 
PCR negative at their 6-week recovery visits. The remaining 6 participants had asymptomatic parasite-
mia at their 6-week recovery visits (3 were blood smear positive and 3 were P. falciparum PCR positive 
and blood smear negative).
Antibodies to VSAs. Anti-VSA IgG antibodies were measured by flow cytometry as previously described 
with minor modifications (76). The Ghana14 P. falciparum isolate was used. Parasites were grown in group 
O erythrocytes, synchronized, harvested at the late trophozoite stage, and cryopreserved. Anti-VSA IgG 
antibodies were measured to assess the appropriateness of  control plasma used in phagocytosis assays; 
VSA assays were performed on plasma from 24 children with acute malaria and their matching 6-week 
recovery samples, pooled plasma from 8 malaria-immune Kenyan adults (positive control for phagocyto-
sis), and plasma from 2 malaria-naive North Americans (negative control for phagocytosis).
Monocyte cytokine production. Monocyte cytokine production was analyzed using freshly isolated 
monocytes from children presenting with acute malaria and 6 weeks following treatment (n = 8 pairs). 
Freshly isolated monocytes from healthy malaria-naive North American adults were used as positive 
controls (n = 4). Monocytes were isolated from whole blood via negative selection with the RosetteSep 
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Human Monocyte Enrichment Cocktail (Stemcell Technologies, 15068). To minimize platelet contami-
nation, the top plasma layer was removed prior to collecting monocytes at the density gradient medium/
plasma interface. Cells were suspended in cell culture medium (RPMI-1640 with 2 mM L-glutamine, 10% 
FBS, 10 mM HEPES, 1 mM sodium pyruvate, 4.5 g/l glucose, 1.5 g/l sodium bicarbonate, and 0.05 mM 
2-ME) and placed in 96-well polypropylene plates at 5 × 104 cells per well (concentration 5 × 105 cells/ml). 
Cells were stimulated with 10 ng/ml LPS (Sigma-Aldrich) and 100 ng/ml P3C (Invivogen) and compared 
with a media-alone control; each condition was performed in duplicate. Cells were cultured for 18 hours 
at 37°C, in 5% CO2, on an orbital shaker. Supernatants were harvested and stored at –80°C; all samples 
were assayed immediately after initial thawing. A multiplex magnetic bead–based immunoassay was used 
to simultaneously measure concentrations of  IL-1β, IL-6, IL-8, IL-10, IL-12p40, and TNF (Millipore) in 
the culture supernatants and plasma.
Targeted digital RNA sequencing. Monocyte inflammatory gene expression profiles were analyzed in 
samples from 6 children with acute uncomplicated malaria, their matching 6-week recovery samples, 
and samples from 5 malaria-naive North American adults. Whole-blood DNA samples from all 6 chil-
dren at 6-week recovery visits were P. falciparum PCR negative. Monocytes were isolated from cryopre-
served PBMCs via negative selection over a magnetic column using a Pan Monocyte Isolation Kit that 
enriches for all three monocyte subsets (Miltenyi Biotec, 130-096-537). Cells were lysed in RNAprotect 
Cell Reagent (Qiagen), and total RNA was prepared using the RNeasy kit (Qiagen) as per the manu-
facturer’s instructions. Total RNA integrity was assessed by an Agilent 2100 Bioanalyzer, and the RNA 
integrity number was calculated (≥8.5 for all samples). Targeted digital RNA sequencing was performed 
using a customized QIAseq Targeted RNA Panel (Human Inflammation and Immunity Transcriptome 
Panel) by the manufacturer (Qiagen).
To determine whether cryopreservation had a significant effect on monocyte transcript levels, we com-
pared gene expression profiles of  cryopreserved versus freshly isolated monocytes from the same North 
American control at the same time point. There were negligible differences in transcript levels between 
cryopreserved and freshly isolated monocytes (r = 0.9762, P < 0.0001, Supplemental Figure 8).
Statistics. Read counts per gene per sample from the QIAseq output were used as input for DESeq2 
(77) differential gene expression analysis to identify significantly upregulated and downregulated genes 
for three different comparisons (Supplemental Table 5): (a) children with acute uncomplicated malaria 
(n = 6) versus their paired 6-week recovery samples (n = 6), using a paired sample design for more robust 
statistical power — with malaria, 51 genes were overexpressed and 74 were underexpressed; (b) children 
with acute uncomplicated malaria (n = 6) versus healthy malaria-naive North American adults (n = 5) 
— with malaria, 114 genes were overexpressed and 86 were underexpressed; and (c) children 6 weeks 
after recovery from uncomplicated malaria (n = 6) versus healthy malaria-naive North American adults 
(n = 5) — at 6-week recovery, 124 genes were overexpressed and 95 were underexpressed.
For each comparison, default settings were used (with a paired design for comparison [a]), and a 
P = 0.05 FDR population-corrected value for significance was required for a gene to be called differen-
tially expressed. Differentially expressed genes (separately for upregulated and downregulated genes, in 
each comparison) were used as input to the WebGestalt (78) functional enrichment analysis, using default 
settings and all 508 genes on the QIAseq Human Inflammation and Immunity Transcriptome Panel as a 
background set for testing. WebGestalt identifies enriched pathways, genes within the enriched pathways, 
and provides images of  pathways maps.
For the remainder of  the assays, statistical analyses were performed as follows. Wilcoxon matched-pairs 
rank test was used to compare acute malaria to matching 6-week recovery samples. Kruskal-Wallis test with 
Dunn’s test for multiple comparisons was used to compare continuous variables among unmatched groups. 
Fisher’s exact test was used to compare categorical variables between acute malaria cases and healthy child 
controls. Friedman test with Dunn’s test for multiple comparisons was used to compare phagocytic activity 
among the three monocyte subsets. Spearman correlation was used to examine the relationship between 
any two variables. Differences were considered significant at P < 0.05. Graphs were constructed and statis-
tical analyses were performed using Prism software (version 7.0; GraphPad).
Study approval. Informed consent was obtained from all participants or their guardians in the appropri-
ate local language (Luo). Ethical approval was obtained from the Institutional Review Board of  Univer-
sity Hospitals Cleveland Medical Center, Cleveland, Ohio, USA (06-11-22), and from the Kenya Medical 
Research Institute Ethical Review Committee (SSC 2207).
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